期刊文献+

加减四妙散对超重糖耐量减低患者炎症因子的影响 被引量:4

Effect of Modified Simiao Powder on the Inflammatory Factors in Overweig ht Patients with Impaired Glucose Tolerance
原文传递
导出
摘要 目的观察加减四妙散对湿热困脾型超重葡萄糖耐量减低(IGT)患者炎症因子的作用。方法超重IGT患者67例随机分为治疗组35例和对照组32例,治疗组在饮食运动指导的同时给予加减四妙散口服,对照组仅给予饮食运动指导,共观察1个月。比较两组治疗前后临床症状积分、空腹血糖(FBG)、餐后2小时血糖(2hPG)、空腹胰岛素(FINS)、白介素-6(IL-6)、脂联素(ADP)、体重指数(BMI)、胰岛素敏感性指数(IAI)的变化。结果两组患者在中医症状积分上较治疗前均有所改善(P<0.05),治疗组患者BMI、FINS和IL-6水平较治疗前降低,ADP水平升高(P<0.05)。治疗组改善中医症状,降低FBG、FINS、IL-6水平和升高ADP、IAI水平均明显优于对照组(P<0.05)。结论加减四妙散可以通过调节炎症因子水平改善超重IGT患者胰岛素抵抗。 Objective To observe the effect of Modified Simiao Powder on the inflammatory factors in impaired glucose tol- erance (IGT) patients with syndrome of damp-heat encumbering the spleen. Methods Sixty-seven IGT patients were random- ized into treatment group (35 cases) and the control group (32 cases). The control group was given diet and exercise guidance. Modified Simiao Powder was added in the treatment group. The treatment lasted for one month. The changes of the clinical symptoms, fasting blood glucose (FBG), 2-hour postprandial blood glucose (2h-PBG), fasting insulin (FINS), interleukin-6 (IL-6), adiponectin (ADP), body mass index (BMI) and insulin activity index (lAD were compared before and after treat- ment. Results The scores of TCM symptoms were improved in both groups (P*~0.05). The levels of BMI, FINS and IL-6 were significantly decreased while ADP increased in the treatment group (P^0.05). Comparing with the control group, Modi- fied Simiao Powder could significantly improve the scores of TCM symptom, decrease the levels of FBG, FINS and IL-6 and in- crease the levels of ADP and IAI (P(0.05). Conclusion Modified Simiao Powder can improve the insulin resistance of IGT patients by modulating the inflammatory factors.
出处 《中医杂志》 CSCD 北大核心 2012年第19期1655-1657,共3页 Journal of Traditional Chinese Medicine
基金 南京市医学科技发展项目(ZKX08031)
关键词 加减四妙散 葡萄糖耐量减低 炎症因子 Modified Simiao Powder impaired glucose tolerance inflammatory factor
  • 相关文献

参考文献4

  • 1钱荣立.2004年中国糖尿病防治指南[M].北京:北京大 学医学出版社,2004 :9.
  • 2李光伟 潘孝仁 Stephenlilioga 等.检测人群胰岛素敏感性的一项新指数.中华内科杂志,1992,31(1):42-42.
  • 3BodenG. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM[J], Diabetes,1997,46(1) :3 — 10.
  • 4周莹,张丽娟.胰岛素抵抗与炎症因子及其相关信号传导通路[J].心血管康复医学杂志,2010,19(1):107-109. 被引量:13

二级参考文献29

  • 1Festa AD, Agostino RD, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome[J]. Circultion 2000; 102 (1): 42-47.
  • 2Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes [J]. J Clin Invest, 2005, 115, 1111-1119.
  • 3Laza MA. How obesity cause diabetes: not a tall tale [J]. Science, 2005, 307 (2): 373-375.
  • 4Mlinar B, Marc J, Janez A, et al. Molecular mechanisms of insulin resistance and associated diseases [J]. Clin Chim Acta, 2007, 375 (1-2): 20-35.
  • 5Lagathu, Claire, Bastard, et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone [J]. Biochemical &Biophysical Research Communications, 2003, 311 (2): 372.
  • 6Senn JJ, Klover PJ, Nowak IA, et al. Interleukin- 6 induces cellular insulin resistance in hepatocytes [J]. Diabetes, 2002, 51 (12): 3391.
  • 7Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6 -dependent insulin resistance in hepatocytes [J]. J Biol Chem, 2003, 278 (16): 13740.
  • 8Sartipy P, Loskutoff DJ. Monocyte ehemo-attractant protein 1 in obesity and insulin resistance [J]. Proc Natl Acad Sci USA, 2003, 100: 7265-7270.
  • 9Kershaw EE, Flier JS. Adipose tissue as an endocrine organ[J]. J Clin Endocrinol Metab, 2004, 89: 2548-2556.
  • 10Takahashi K, Mizuarai S, Araki H, et al. Adiposity elevates plasma MCP- 1 levels leading to the increased CD11b- positive monocytes in mice [J]. J Biol Chem, 2003, 278: 46654- 44660.

共引文献16

同被引文献59

引证文献4

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部